Depression News and Research

Latest Depression News and Research

Evotec partners with ChemBridge to expand high throughput screening collection

Evotec partners with ChemBridge to expand high throughput screening collection

PsychoGenics establishes alliance with KineMed to provide specialized neurogenesis services

PsychoGenics establishes alliance with KineMed to provide specialized neurogenesis services

Study finds link between poor sleep quality and functional disability in RA patients

Study finds link between poor sleep quality and functional disability in RA patients

NatureBright's light therapy product recommended for relieving Seasonal Affective Disorder

NatureBright's light therapy product recommended for relieving Seasonal Affective Disorder

Study explores levels of burden and depression in caregivers with sensory impairment

Study explores levels of burden and depression in caregivers with sensory impairment

Two Uofl professors provide reference works in oncology field

Two Uofl professors provide reference works in oncology field

Research roundup: Access to care in Mass.; Mental health spending; Gender and medical debt: How much do Americans know about health law?

Research roundup: Access to care in Mass.; Mental health spending; Gender and medical debt: How much do Americans know about health law?

Study discovers similarities between child soldier trauma in Uganda and children in Northern Ireland

Study discovers similarities between child soldier trauma in Uganda and children in Northern Ireland

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

New model of dementia care reduces emergency department visits, hospitalizations

New model of dementia care reduces emergency department visits, hospitalizations

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Rhabdomyolysis episode at University of Iowa signals a public health crisis

Rhabdomyolysis episode at University of Iowa signals a public health crisis

Private health sector employment share in the US reaches all-time high of 10.7%

Private health sector employment share in the US reaches all-time high of 10.7%

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

New study: Testosterone administration leads to significant reduction in mind reading

New study: Testosterone administration leads to significant reduction in mind reading

Evotec signs definitive agreement to acquire all shares in Kinaxo

Evotec signs definitive agreement to acquire all shares in Kinaxo

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen third quarter total revenue increases 26% to $7,068,000

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.